Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases
about
Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathwayFrom Inflammation to Prostate Cancer: The Role of InflammasomesEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsPathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesPlasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancerMacrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapySecretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironmentProstate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissueCytokine profiling of docetaxel-resistant castration-resistant prostate cancer.Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone miceMorphological effects on expression of growth differentiation factor 15 (GDF15), a marker of metastasis.Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancerMolecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast CancerMacrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer.The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.Development of animal models underlining mechanistic connections between prostate inflammation and cancerMarked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.Collagenous and non-collagenous biochemical markers of bone metastases from prostate cancer.Growth/differentiation factor-15: prostate cancer suppressor or promoter?Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia.Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2).Collagen isoform shift during the early phase of reverse left ventricular remodelling after relief of pressure overload.Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate.Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation.Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer.Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer.Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cellsAn Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis
P2860
Q24620497-0EAB7C23-70C9-4A89-8DEF-BE85D5526088Q26739947-885EB257-4A8B-4D28-93B8-C7E58ABC0172Q26827810-DD9F7DCD-8B71-4C40-AEB5-63D7664309B8Q28393898-E4D4FBD1-03E4-43C1-9F98-1525E41CB0EAQ31049380-298FFF5B-E034-4053-A4D2-CEDA20F2B661Q33723662-F3C7FC2E-2A1E-4395-BB39-81F5B03665BEQ34045939-BAE07E72-3E22-4DD0-8FA1-13085A69AA19Q34099900-A02CCD6F-82F9-4D45-A97F-C5C38112A992Q34405669-5E201E42-EF92-4128-AC62-EFF2544BCC91Q35051499-C6F9E4BC-360B-4BE8-8FF9-A38D164F6587Q35148340-5D924ECB-9F30-49A3-B6C1-33C1B6CD20ADQ35175108-C8145379-6AC4-4BFF-8303-F9BFDAB8A7FCQ35475443-34C82795-2E57-4722-9CDD-3E008D3D8983Q35563909-12A0391D-2025-4933-8AB3-2B3435D9B39DQ35821663-A3D6DCB2-C268-403F-9C1D-6DE48A35AF3AQ36076068-3A1F327A-141F-4889-BBF9-185A0EB06E32Q36440214-E7F1F8DB-56A6-4ED8-98AC-ECE414DD789EQ36570789-09172A1B-B392-4710-B264-609FEF93E6E7Q36592451-9469C84F-7C02-44D8-98B5-D53CFC7F901AQ36718905-A8541F38-F59A-4ADE-B14A-0237AF1793B0Q36746688-615C55F3-39C4-4DA0-B99A-5870D9E4ACC0Q37687793-76635035-0E2E-4494-BEFE-6880D27377E4Q37803537-88C760C2-95DF-41D9-951F-306C6751C8F4Q37988746-D713A92A-1F30-4DD0-AA0D-17C7EBB4040DQ38751466-A8A1AB38-03AD-4EFC-9174-78603995F798Q39218029-B9961AA6-CBEE-414F-AA9B-F5F471C8276FQ39284945-261B58FD-1E17-4A7F-A427-C5CF2EBA94D9Q39294665-01890147-7E35-4D88-94AD-285E6F7123BEQ39492314-4A2EDA80-D617-4999-AC6D-BA7162C71ADDQ43125020-D7CA5D56-50FC-419F-B897-C07F497361A6Q43833419-AF216DF4-2D80-4357-B1F5-F651A0AB0A72Q47129121-EBC7BC53-1BB2-4751-BBDF-9AB6238303A6Q48574810-30E76EA2-AB64-4182-8002-9E823675D5BAQ52630342-ECD9FC29-6DE1-42DA-8098-94B2DAA3A0F2Q55284651-ED6C1035-5D04-495E-B42D-75AF1B87A092Q57066655-0F31B642-111D-4E44-A1A6-D6EA7532936DQ57826829-034129AC-0F41-4A3F-97B7-16B89AC8FEED
P2860
Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@ast
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@en
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@nl
type
label
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@ast
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@en
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@nl
prefLabel
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@ast
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@en
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@nl
P2093
P3181
P1476
Serum macrophage inhibitory cy ...... rostate cancer bone metastases
@en
P2093
David A Brown
Guillermo Blanco Sequeiros
Juha Risteli
Katri S Selander
Mark Hunter
Renee Desmond
Samuel N Breit
Teija Parpala
P3181
P356
10.1158/1055-9965.EPI-06-0841
P407
P577
2007-03-01T00:00:00Z